Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice

Brain Research

Volumn 1099, Issue 1, 2006, Pages 189-198

  Alpár, Alán ^a   Ueberham, Uwe ^b   Brückner, Martina K ^b   Seeger, Gudrun ^b   Arendt, Thomas ^b   Gärtner, Ulrich ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

APP; Morphology; Neocortex; Plasticity; Pyramidal neuron

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DENDRITE; DENDRITIC SPINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SENILE PLAQUE; SOMATOSENSORY CORTEX; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DENDRITES; DENDRITIC SPINES; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; SOMATOSENSORY CORTEX;

MUS MUSCULUS;

EID: 33746079643     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.109     Document Type: Article

References (67)

1. Alpár A., Palm K., Schierwagen A., Arendt T., and Gärtner U. Expression of constitutively active p21H-rasval12 in postmitotic pyramidal neurons results in increased dendritic size and complexity. J. Comp. Neurol. 467 (2003) 119-133
2. Alpár A., Ueberham U., Brückner M.K., Arendt T., and Gärtner U. The expression of wild-type human amyloid precursor protein affects the dendritic phenotype of neocortical pyramidal neurons in transgenic mice. Int. J. Dev. Neurosci. 24 (2006) 133-140
3. Chen Q.S., Wei W.Z., Shimahara T., and Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77 (2002) 354-371
4. Cullen W.K., Wu J., Anwyl R., and Rowan M.J. β-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. NeuroReport 8 (1996) 87-92
5. Cummings B.J., Pike C.J., Shankle R., and Cotman C.W. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17 (1996) 921-933
6. DeKosky S.T., Scheff S.W., and Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5 (1996) 417-421
7. Duan H., Wearne S.L., Morrison J.H., and Hof P.R. Quantitative analysis of the dendritic morphology of corticocortical projection neurons in the macaque monkey association cortex. Neuroscience 114 (2002) 349-359
8. Dutar P., Potier B., and Lamour Y. Short-term effects of beta-amyloid protein on CA1 hippocampal neurons in young and aged rats: a study of calcium-dependent events. Neurodegeneration 3 (1994) 119-128
9. Elston G.N., and Rockland K.S. The pyramidal cell of the sensorimotor cortex of the macaque monkey: phenotypic variation. Cereb. Cortex 12 (2002) 1071-1078
10. Flood J.F., Morley J.E., and Roberts E. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3363-3366
11. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press
12. Froemke R.C., Poo M.M., and Dan Y. Spike-timing-dependent synaptic plasticity depends on dendritic location. Nature 434 (2005) 221-225
13. Gärtner U., Alpár A., Reimann F., Seeger G., Heumann R., and Arendt T. Constitutive Ras activity induces hippocampal hypertrophy and remodeling of pyramidal neurons in synRas mice. J. Neurosci. Res. 77 (2004) 630-641
14. Giulian D., Haverkamp L.J., Yu J.H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo L.M., and Roher A.E. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16 (1996) 6021-6037
15. Glaser J.R., and Glaser E.M. Neuron imaging with Neurolucida-A PC-based system for image combining microscopy. Comput. Med. Imaging Graph. 14 (1990) 307-317
16. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., and Selkoe D.J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
17. Hampel H., Teipel S.J., Alexander G.E., Horwitz B., Teichberg D., Schapiro M.B., and Rapoport S.I. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch. Neurol. 55 (1998) 193-198
18. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
19. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., and Hyman B.T. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17 (1997) 7053-7059
20. Jacobs B., Driscoll L., and Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol. 386 (1997) 661-680
21. Jacobs B., Schall M., Prather M., Kapler E., Driscoll L., Baca S., Jacobs J., Ford K., Wainwright M., and Treml M. Regional dendritic and spine variation in human cerebral cortex: a quantitative golgi study. Cereb. Cortex 11 (2001) 558-571
22. Jhamandas J.H., Cho C., Jassar B., Harris K., MacTavish D., and Easaw J. Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol. 86 (2001) 1312-1320
23. Jin L.W., Ninomiya H., Roch J.M., Schubert D., Masliah E., Otero D.A.C., and Saitoh T. Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14 (1994) 5461-5470
24. Kar S., Seto D., Gaudreau P., and Quirion R. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16 (1996) 1034-1040
25. Kasa P., Rakonczay Z., and Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52 (1997) 511-535
26. Knowles R.B., Gomez-Isla T., and Hyman B.T. Abeta associated neuropil changes: correlation with neuronal loss and dementia. J. Neuropathol. Exp. Neurol. 57 (1998) 1122-1130
27. Knowles R.B., Wyart C., Buldyrev S.V., Cruz L., Urbanc B., Hasselmo M.E., Stanley H.E., and Hyman B.T. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5274-5279
28. Laberge D. Sustained attention and apical dendrite activity in recurrent circuits. Brain Res. Brain Res. Rev. 50 (2005) 86-99
29. Laberge D. Apical dendrite activity in cognition and consciousness. Conscious Cogn (2005 (Nov 7)) (electronic publication ahead of print)
30. Larkman A. Dendritic morphology of pyramidal neurones of the visual cortex of the rat: III. Spine distributions. J. Comp. Neurol. 306 (1991) 332-343
31. Larner A.J. The cortical neuritic dystrophy of Alzheimer's disease: nature, significance, and possible pathogenesis. Dementia 6 (1995) 218-224
32. Le R., Cruz L., Urbanc B., Knowles R.B., Hsiao-Ashe K., Duff K., Irizarry M.C., Stanley H.E., and Hyman B.T. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J. Neuropathol. Exp. Neurol. 60 (2001) 753-758
33. Lubke J., Egger V., Sakmann B., and Feldmeyer D. Columnar organization of dendrites and axons of single and synaptically coupled excitatory spiny neurons in layer 4 of the rat barrel cortex. J. Neurosci. 20 (2000) 5300-5311
34. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol. Histopathol. 10 (1995) 509-519
35. Mattson M.P. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25 (1994) 439-450
36. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
37. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
38. Mattson M.P., Partin J., and Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807 (1998) 167-176
39. McKee A.C., Kowall N.W., Schumacher J.S., and Beal M.F. The neurotoxicity of amyloid beta protein in aged primates. Amyloid 5 (1998) 1-9
40. Meda L., Cassatella M.A., Szendrei G.I., Otvos Jr. L., Baron P., Villalba M., Ferrari D., and Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374 (1995) 647-650
41. Meziane H., Dodart J.C., Mathis C., Little S., Clemens J., Paul S.M., and Ungerer A. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12683-12688
42. Moolman D.L., Vitolo O.V., Vonsattel J.P., and Shelanski M.L. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 33 (2004) 377-387
43. Mountcastle V.B. The columnar organization of the neocortex. Brain 120 (1997) 701-722
44. O'Leary J.L. Structure of the area striata in the cat. J. Comp. Neurol. 75 (1941) 131-164
45. Paresce D.M., Ghosh R.N., and Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17 (1996) 553-565
46. Perez R.G., Zheng H., Van der Ploeg L.H., and Koo E.H. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17 (1997) 9407-9414
47. Pettit D.L., Shao Z., and Yakel J.L. β-amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21 (2001) RC120
48. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
49. Raymond C.R., Ireland D.R., and Abraham W.C. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res. 968 (2003) 263-272
50. Richardson J.S., Zhou Y., and Kumar U. Free radicals in the neurotoxic actions of beta-amyloid. Ann. N. Y. Acad. Sci. 777 (1996) 362-367
51. Sandbrink R., and Beyreuther K. Unraveling the molecular pathway of Alzheimer's disease: research about presenilins gather momentum. Mol. Psychiatry 1 (1996) 438-444
52. Schaefer A.T., Larkum M.E., Sakmann B., and Roth A. Coincidence detection in pyramidal neurons is tuned by their dendritic branching pattern. J. Neurophysiol. 89 (2003) 3143-3154
53. Scheibel A.B., and Tomiyasu U. Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60 (1978) 1-8
54. Shivers B.D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7 (1988) 1365-1370
55. Simmons M.A., and Schneider C.R. Amyloid beta peptides act directly on single neurons. Neurosci. Lett. 150 (1993) 133-136
56. Soloway A.S., Pucak M.L., Melchitzky D.S., and Lewis D.A. Dendritic morphology of callosal and ipsilateral projection neurons in monkey prefrontal cortex. Neuroscience 109 (2002) 461-471
57. Terai K., Iwai A., Kawabata S., Tasaki Y., Watanabe T., Miyata K., and Yamaguchi T. Beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104 (2001) 299-310
58. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
59. Tomidokoro Y., Harigaya Y., Matsubara E., Ikeda M., Kawarabayashi T., Okamoto K., and Shoji M. Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor. Neurosci. Lett. 292 (2000) 155-158
60. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7 (2004) 1181-1183
61. Turner P.R., O'Connor K., Tate W.P., and Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70 (2003) 1-32
62. Ueda K., Fukui Y., and Kageyama H. Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein. Brain Res. 639 (1994) 240-244
63. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., and Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30 (2002) 552-557 (Review)
64. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., and Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924 (2002) 133-140
65. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
66. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., and Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389 (1997) 689-695
67. Zhou Y., Gopalakrishnan V., and Richardson J.S. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67 (1996) 1419-1425